tradingkey.logo

WGRX

WGRX
查看詳細走勢圖
0.486USD
+0.007+1.42%
收盤 12/19, 16:00美東報價延遲15分鐘
43.45M總市值
虧損本益比TTM

WGRX

0.486
+0.007+1.42%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.42%

5天

-15.16%

1月

-0.59%

6月

-59.86%

今年開始到現在

0.00%

1年

0.00%

查看詳細走勢圖

TradingKey WGRX股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Wellgistics Health Inc當前公司基本面數據相對穩定,增長潛力穩定。當前估值合理,在醫療設備與耗材行業排名161/208位。機構持股佔比非常高,中期看,股價處於下降通道。近一個月,市場表現一般,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

WGRX評分

相關信息

行業排名
161 / 208
全市場排名
480 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

WGRX亮點

亮點風險
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
業績增長期
公司處於發展階段,最新年度總收入18.13M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入18.13M美元
估值高估
公司最新PE估值-0.38,處於3年歷史高位
機構加倉
最新機構持股1.68M股,環比增加43.54%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉0.00股

WGRX新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

WGRX簡介

Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
公司代碼WGRX
公司Wellgistics Health Inc
CEOMr. Brian Norton
網址https://wellgisticshealth.com/

常見問題

WGRX(WGRX)的當前股價是多少?

WGRX(WGRX)的當前股價是 0.486。

WGRX 的股票代碼是什麼?

WGRX的股票代碼是WGRX。

WGRX股票的52週最高點是多少?

WGRX股票的52週最高點是7.040。

WGRX股票的52週最低點是多少?

WGRX股票的52週最低點是0.336。

WGRX的市值是多少?

WGRX的市值是43.45M。

WGRX的淨利潤是多少?

WGRX的淨利潤為-6.86M。

現在WGRX(WGRX)的股票是買入、持有還是賣出?

根據分析師評級,WGRX(WGRX)的總體評級為--,目標價格為--。

WGRX(WGRX)股票的每股收益(EPS TTM)是多少

WGRX(WGRX)股票的每股收益(EPS TTM)是-1.272。
KeyAI